Author: CLAdmin

MADISON, Wis., January 20, 2026 – Cellular Logistics Inc., a pioneering Madison-based biotechnology company dedicated to transforming the treatment of heart disease through innovative regenerative medicine, today announced the receipt of new funding specifically earmarked for the development of potency assays critical to its flagship...

Madison, WI, January 9, 2024 – Cellular Logistics Inc. (CL) in Madison, Wisconsin, and Allele Biotechnology Inc. (ALLELE) in San Diego, California, have entered a collaboration to develop regenerative medicine products to treat ischemic heart disease. The relationship has been recently bolstered by the Catalyze award that...

MADISON, Wis., October 24, 2022 – Cellular Logistics has been awarded a $337,000 SBIR grant from the National Institutes of Health to further evaluate the functional immune and angiogenic (blood vessel growth) responses of the company's Cardiac Fibroblast Matrix product, CFX™ Solus, for the treatment...

MADISON, WI, May 16, 2022 – Cellular Logistics, a Madison, Wisconsin company that is creating a new way to restore heart function and help patients with heart damage is launching a new financing round to advance its product, Tandem™, to the next stage of product development, and moving...